光合生物色素-蛋白质复合物的多样性

通过对近年来放氧型光合生物有关研究结果的概括分析,提出放氧型光合生物光系统Ⅰ、光系统Ⅱ及捕光色素-蛋白质复合物具有多样性,并根据其PSⅠ复合物的77 K荧光发射特点,指出放氧型光合生物光合系统中的能量传递方式也可能存在多样性.     

光系统Ⅱ核心复合物的化学修饰及其光谱性质研究

光系统II核心复合物的化学修饰及其光谱性质研究 李淑芹 陈耀东 唐崇钦 李良璧 匡廷云 （中国科学院植物研究所光合作用研究中心,北京100093）     

Differential recognition of MHC class I molecules of xeno-/allo-endothelial cells by human NK cells

Using human umbilical vein endothelial cells (HUVEC) and porcine aortic endothelial cells (PAEC) as target cells, human peripheral blood NK cells (PBNK) and NK92 cells as effector cells, the differential cytotoxicities of NK cells to allo- and xeno-endothelial cells were studied. The influence of MHC class I molecules on the cytotoxicity of human NK cells was assayed using acid treatment, and blockades of MHC class I antigens, CD94 and KIR (NKB1). The results indicated that the killing of PAEC by the two kinds of NK cells is higher than that of HUVEC. After acid-treatment, the cytotoxicity of the two kinds of NK cells to PAEC and HUVEC is significantly enhanced, but the magnitude of the enhancement is different. The enhancement of NK killing to acid treated HUVEC is much greater than that to PAEC. Blockade of CD94 mAb did not alter the NK cytotoxicity, while blockade of NKB1 mAb enhanced the cytotoxicity of PBNK to HUVEC and PAEC by 95% and 29% respectively. The results above suggested that the different     

Structural Analysis of Peptides of PSⅡ Light-harvesting Complexes in Siphonous Green Algae,Codium fragile

Peptide composition and arrangement of 4 major light harvesting complexes LHCP1-3 and LHCP3′isolated from siphonous green algae （Codium fragile (Sur.) Hariot.） were investigated. LHCP1 showed five main peptides, 34.4, 31.5, 29.5, 28.2 and 26.5 kD in SDS PAGE, the 34.4 and 31.5 kD peptides were never found in higher plants. LHCP3 contained the other four kinds of LHCP1 peptides except 34.4 kD, while LHCP3′consisted of only 28.2 and 26.5 kD peptides. We found that 34.4, 28.2 and 26.5 kD peptides were easy to decompose from LHCP 1 when subjected to SDS PAGE without pretreatment. They might be located at the exterior of LHCP1, while the 31.5 and 29.5 kD peptides were at the central part. The 28.2 and 26.5 kD peptides often occurred in CPa, the center complex of PSⅡ. They are possibly the LHCⅡ peptides tightly associated with CCⅡ. According to the results described above, a peptide map of LHCP1 was sketched.     

绿藻假根羽藻色素-蛋白复合物的分离及其特性研究

采用聚丙烯酰胺凝胶电泳(PAGE)和蔗糖密度梯度超速离心方法分离了假根羽藻(Bryopsis corticulans)的色素-蛋白复合物,并对其特性进行分析。结果表明:采用PAGE分离得到7条色素-蛋白复合物带,分别是CPⅠa1、CPⅠa2、CPⅠ、LHCP₁、LHCP₂、CPa、LHCP₃₊₃,和2条游离色素(free pigment,FP)FCa、FC。用改进的不连续蔗糖密度梯度离心法分离到五条带。区带Ⅰ是FP;区带Ⅱ主要是小分子量的PSⅡ捕光复合物LHCP₃₊₃;区带Ⅲ以PSⅡ捕光复合物的聚集体LHCP1为主,区带Ⅱ和Ⅲ的吸收光谱中除了Chla外,还含有大量的Chlb和管藻黄素,是管藻黄素-Chla/b-蛋白质复合物;区带Ⅳ在PAGE中只显示一条带,光谱中有Chlb吸收肩峰,含有66和56kDa两种多肽,是较小的PSⅠ复合物CPⅠa。     

Manganese(II) complexes of an acyclic phenol-based dinucleating ligand with four methoxyethyl chelating arms: synthesis, structure, magnetism and electrochemistry

Dinuclear manganese(II) complexes [Mn₂(bomp)(PhCO₂)₂]BPh₄ (1), [Mn₂(bomp)(MeCO₂)₂]BPh₄ (2), and [Mn₂(bomp)(PhCO₂)₂]PF₆ (3) were synthesized with a dinucleating ligand 2,6-bis[bis(2-methoxyethyl)aminomethyl]-4-methylphenol [H(bomp)]. Dinuclear zinc complex [Zn₂(bomp)(PhCO₂)₂]PF₆ (4) was also synthesized for the purpose of comparison. X-ray analysis revealed that the complex 1·CHCl₃ contains two manganese ions bridged by the phenolic oxygen and two benzoate groups, forming a μ-phenoxo-bis(μ-benzoato)dimanganese(II) core. Magnetic susceptibility measurements of 1–3 over the temperature range 1.8–300 K indicated antiferromagnetic interaction (J=−4 to −6 cm⁻¹). Cyclic voltammograms of 3 showed a quasi-reversible oxidation process at +0.9 V versus a saturated sodium chloride calomel reference electrode, assigned to Mn^IIMn^II/Mn^IIMn^III.     

The structure of the dichromium compound Cr2(μ-OH)2(μ-3,5Cl2-form)2(η-3,5Cl2-form)2

With exposure to trace amounts of air and moisture, the Cr₂(II, II) complex Cr₂(μ-3,5Cl₂-form)₄, where 3,5Cl₂-form is [(3,5-Cl₂C₆H₃)NC(H)N(3,5-Cl₂C₆H₃)⁻], undergoes an oxidative addition reaction. Structural information from the X-ray crystal structure of the edge-sharing bioctahedral (ESBO) Cr₂(III, III) product Cr₂(μ-OH)₂(μ-3,5Cl₂-form)₂(η²-3,5Cl₂-form)₂ (1) indicates 1 has a significantly longer Cr–Cr distance [2.732(2) Å] than Cr₂(μ-3,5Cl₂-form)₄ [1.9162(10) Å], but the shortest Cr–Cr distance in an ESBO Cr₂(III, III) complex recorded to date.     

A hexaimino cryptand containing naphthyl groups; structural characterization of mononuclear complexes and catalysis in hydrolysis of p-nitrophenyl phosphate

Mononuclear metal complexes of a hexaimino cryptand containing three naphthyl groups have been prepared and the structure of the copper(I) complex was determined by X-ray diffraction. The complexes show acceleration of hydrolysis of p-nitrophenyl phosphate ester.     

传染性支气管炎病毒N蛋白CTL表位与BF2*15鸡MHC I基序的相互作用

【目的】近年来鸡传染性支气管炎病毒在国内鸡群呈现流行趋势,尤其是变异毒株的出现,加剧了对鸡群的危害。鸡主要组织相容复合体蛋白(MHC I)通过特定的基序结合抗原表位多肽,进而识别感染病毒的细胞并引起免疫反应,达到清除病毒的效果。鉴定BF2*15鸡主要组织相容复合体(MHC I)的结合基序。【方法】采用同源建模、分子动力学和分子对接等计算方法,构建了传染性支气管炎病毒(IBV)N蛋白表位多肽和鸡MHC I BF2*15之间的复合物结构,来探索BF2*15识别抗原表位多肽的潜在结合基序。【结果】通过对该复合物的相互作用关系分析,鉴定出BF2*15鸡主要组织相容复合体(MHC I)的一条潜在结合基序"x-Arg-xx-x-Arg"。【结论】解释了传染性支气管炎病毒N蛋白CTL表位与BF2*15鸡MHC I基序的相互作用原理,该研究结果对了解传染性支气管炎病毒免疫机制以及基于特定基序筛选和设计通用疫苗具有借鉴意义。     

MHC Class I Immunopeptidome: Past,Present, and Future

In the 35 years since the revelation that short peptides bound to major histocompatibility complex class I and II molecules are the secret of the major histocompatibility complex–restricted nature of T-cell recognition, there has been enormous progress in characterizing the immunopeptidome, the repertoire of peptide presented for immunosurveillance. Here, the major milestones in the journey are marked, the contribution of proteasome-mediated splicing to the immunopeptidome is discussed, and exciting recent findings relating the immunopeptidome to the translatome revealed by ribosome profiling (RiboSeq) is detailed. Finally, what is needed for continued progress is opined about, which includes the infusion of talented young scientists into the antigen-processing field, currently undergoing a renaissance; thanks in part to the astounding success of T-cell–based cancer immunotherapy.